Novo Nordisk

YTD

ALL

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell Novo Nordisk and other ETFs, options, and stocks.

About NVO

Novo Nordisk A/S is a global healthcare company, which engages in the discovery, development, manufacturing and marketing of pharmaceutical products. It operates through the Diabetes and Obesity Care and Rare Disease segments.

CEO

Maziar Mike Doustdar

CEOMaziar Mike Doustdar

Employees

68,794

Employees68,794

Headquarters

Bagsværd, Capital Region

HeadquartersBagsværd, Capital Region

Founded

1923

Founded1923

Employees

68,794

Employees68,794

NVO Key Statistics

Market cap

176.56B

Market cap176.56B

Price-Earnings ratio

11.74

Price-Earnings ratio11.74

Dividend yield

3.01%

Dividend yield3.01%

Average volume

14.46M

Average volume14.46M

High today

$41.29

High today$41.29

Low today

$40.34

Low today$40.34

Open price

$40.98

Open price$40.98

Volume

10.11M

Volume10.11M

52 Week high

$81.44

52 Week high$81.44

52 Week low

$35.12

52 Week low$35.12

NVO News

TipRanks 2h

Mixed options sentiment in Novo Nordisk with shares down 0.26%

Mixed options sentiment in Novo Nordisk (NVO), with shares down 10c near $40.83. Options volume roughly in line with average with 50k contracts traded and calls...

Investor's Business Daily 5h

Eli Lilly's Pill Lags Novo Nordisk's In First Week. Why Stock Rallied.

Technology Eli Lilly's Pill Lags Novo Nordisk's In First Week. Why Stock Rallied. Licensing Eli Lilly's (LLY) oral weight-loss drug, Foundayo, nabbed 1,390 pres...

MarketWatch 7h

Lilly’s new GLP-1 pill is off to a ‘robust’ start

The early success of Eli Lilly’s new GLP-1 pill is the latest signal that Americans are still eager for pills that can help them lose weight. Foundayo was appr...

Analyst ratings

63%

of 35 ratings

Buy

31.4%

Hold

62.9%

Sell

5.7%

More NVO News

The Motley Fool 10h

Is Viking Therapeutics the Ultimate Millionaire-Maker Obesity Stock for 2026?

Pharmaceutical and biotech companies may offer your portfolio a sense of stability, and this is for one good reason: Patients need their medical treatments, so...

Simply Wall St 19h

Assessing Novo Nordisk’s Valuation After Recent Share Price Swings

Advertisement What Novo Nordisk’s Recent Performance Signals for Investors Novo Nordisk (NYSE:NVO) has drawn fresh attention after a mixed run in its share pe...

Nasdaq 1d

Should You Forget CVS Health and Invest in a Purer Healthcare Play?

Key Points CVS Health has a far more diversified business than Novo Nordisk. Both approaches have perks and disadvantages. These two healthcare leaders seem...

TipRanks 1d

Novo Nordisk Maps Heart Risk in New Diabetes Patients Across Southeast Asia

Novo Nordisk (NVO) announced an update on their ongoing clinical study. Unlock hedge fund-level data and powerful investing tools for smarter, sharper decision...

Simply Wall St 2d

Is Novo Nordisk Now An Opportunity After Recent Share Price Weakness?

If you are wondering whether Novo Nordisk's current share price still reflects its long term potential, the key question is how its fundamentals stack up agains...

Investor's Business Daily 3d

Big Pharma Deepens AI Ties. What It Means For Novo, Novartis.

Technology Big Pharma Deepens AI Ties. What It Means For Novo, Novartis. Licensing Novo Nordisk (NVO) and Novartis (NVS) have forged deeper ties to AI trailblaz...

TipRanks 3d

Novo Nordisk Stock Is Cheap and Offers a 5% Dividend Yield

The stock of European pharmaceutical giant Novo Nordisk (NVO) is cheap at current levels and offers shareholders a hefty dividend yield of nearly 5%. Claim 30%...

Similar Marketcap

This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.

Popular Stocks

This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset

Newly Listed

This list is generated by showing companies that recently went public.